Navigation Links
Neurochem reports results for third quarter of fiscal 2007
Date:11/7/2007

scuss outstanding issues raised with respect to the eprodisate (KIACTA(TM)) application and a decision from the EMEA is expected by year end, or shortly thereafter. The Marketing Authorization Application is being reviewed under the EMEA's centralized procedure. An authorization from the EMEA would apply to all 27 European Union member states, as well as Norway and Iceland.

Reimbursable costs revenue amounted to $73,000 for the current quarter ($332,000 for the nine-month period), compared to $152,000 for the same period in the previous year ($534,000 for the nine-month period) and consists of costs reimbursable by Centocor in respect of eprodisate (KIACTA(TM))-related activities. The Company earns no margin on these reimbursable costs.

Research and development expenses, before research tax credits and grants, amounted to $11,964,000 for the current quarter ($43,533,000 for the nine-month period), compared to $12,890,000 for the same period in the previous year ($37,546,000 for the nine-month period). The increase in the nine-month period compared to the same period the previous year is due to expenses incurred in relation to the development of tramiprosate (ALZHEMED(TM)), primarily in respect of the ongoing Phase III clinical trial in Europe and the North American open-label extension of the Phase III study, as well as the conduct of a QT cardiac status Phase I study. Tramiprosate (ALZHEMED(TM)) is the Company's investigational product candidate for the treatment of Alzheimer's disease (AD), which completed its 18-month North American Phase III clinical trial during the first quarter of 2007. In August 2007, the Company announced top-line results from this trial, designed to assess the safety, efficacy and disease modification effect of tramiprosate (ALZHEMED(TM)) for the treatment of AD. The North American Phase III clinical trial, despite the descriptive data showing numerical differences in favor of tramiprosate (ALZHEMED(TM)), did not demonstrate a
'/>"/>

SOURCE NEUROCHEM INC.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
2. Haemacure Reports Third Quarter 2007 Results
3. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
4. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
5. MDS Reports Third Quarter 2007 Results
6. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
7. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
8. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
9. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
10. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
11. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Liberty University has received accreditation for its resident ... Council for Accreditation of Counseling & Related Educational Programs ... for Counseling & Family Studies , is under the leadership ... School of Behavioral Sciences. Prior to the formation of the ...
(Date:1/22/2015)... 22, 2015 Woodloch Pines, an all-inclusive ... selected by TripAdvisor as the number one best large hotel ... in the world for their annual Travelers’ Choice Awards. ... . The website is home to millions of unbiased and ...
(Date:1/22/2015)... January 23, 2015 VogueQueen is a seasoned ... prices and many designers are thrilled to have it lead ... announces its new collection of prom dresses for the global ... drive the strategic vision and he focuses on continuing the ...
(Date:1/22/2015)... EAGAN, Minn. (PRWEB) January 22, 2015 Blue ... discover those Minnesotans who exemplify what it means to “Live ... a chance for people to share their stories about how ... adversity or simply inspired others by living in the moment. ...
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and ... Merchandise Show to bestow a Juvent Sports Achievement award ... Arlene McKitrick. The award commemorated and congratulated McKitrick for ... She won her first amateur tournament in 1979 and ...
Breaking Medicine News(10 mins):Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3
... ... from its new upper extremity range, bebionic. Launched at the ISPO World congress in May, ... of approximately 9,000 Euros, or $11,000 USD. , ... (PRWeb UK) July 1, 2010 -- RSLSteeper have announced the pricing for ...
... , ... new manufacturing techniques that provide a higher quality, more fashionable product. Overcoming the knitting ... , ... 17, 2010 --When seeking a non-binding top or diabetic sock you want comfort, ...
... ... Stamen Medical Systems, LLC, a Martinez, GA based provider of the Erec-Tech ... to announce their most recent Medicare Re-Accreditation score of 96. As the ... of compliance and ethics is imperative during these current economic times and ...
... infants at risk of life-threatening conditions ... that are clinically difficult to detect. These include late-onset ... in the blood, and necrotizing enterocolitis, a condition in ... Poon and colleagues, at the The Chinese University of ...
... stem cells have enticed scientists because of the potential to ... targeting the tumor,s most voracious cells. Now, researchers at Children,s ... in a model of the most common form of human ... stem cells may vary from tumor to tumor, depending upon ...
... , THURSDAY, July 1 (HealthDay News) -- Too much Wheel ... for seniors, mental state, new research suggests. Researchers analyzed data ... adults over age 65 spent almost three times more of their ... while the younger folks considered vegging out in front of the ...
Cached Medicine News:Health News:RSLSteeper announces pricing for new bionic hand 2Health News:Diabetic Sock Manufacturing Techniques Improved 2Health News:Stamen Medical Systems Receives Medicare Re-Accreditation and The Exemplary Provider Award 2Health News:JCI online early table of contents: July 1, 2010 2Health News:JCI online early table of contents: July 1, 2010 3Health News:JCI online early table of contents: July 1, 2010 4Health News:JCI online early table of contents: July 1, 2010 5Health News:JCI online early table of contents: July 1, 2010 6Health News:JCI online early table of contents: July 1, 2010 7Health News:Cancer stem cells are not 1 size fits all, lung cancer models show 2Health News:Older Folks Watch More TV, Get Less Out of It 2Health News:Older Folks Watch More TV, Get Less Out of It 3
(Date:1/23/2015)... 2015  Mallinckrodt plc (NYSE: MNK ) announced ... share repurchase program. The open-ended authorization permits the company ... ordinary shares. "Funding additional initiatives and ... we continue to pursue a range of focused growth ...
(Date:1/22/2015)... Jan. 22, 2015  BiOptix is pleased to announce the ... President of Chemistry and Biochemistry. Scott joins the company after ... and Amgen throughout the course of his nearly 20 ... "Scott is a nationally recognized thought leader in the ...
(Date:1/22/2015)...  Bio-Techne Corporation (NASDAQ: TECH ) announced today ... the new Simple Plex platform through its Proteins Platform ... re-branding of the previously acquired CyPlex instrument platform from ... transformative immunoassay technology which integrates an innovatively designed microfluidic ...
Breaking Medicine Technology:Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2Bio-Techne Launches Simple Plex Platform 2Bio-Techne Launches Simple Plex Platform 3
... Diagnostics Incorporated (NYSE: DGX ), the world,s ... that for the third quarter ended September 30, 2010, ... $1.13 per diluted share, from $192 million, or $1.02 ... Third quarter 2010 results include a benefit of $0.08 ...
... Stryker Corporation (NYSE: SYK ) reported operating ... Third Quarter Highlights ... as reported) to $1,768 million Orthopaedic Implants sales increased ... MedSurg Equipment sales increased 16.3% on a constant currency ...
Cached Medicine Technology:Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010 2Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010 3Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010 4Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010 5Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010 6Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010 7Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010 8Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010 9Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010 10Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010 11Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 2Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 3Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 4Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 5Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 6Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 7Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 8
The Wellwash 4 Mk 2 combines high performance and flexibility with reliability, simplicity and ease of use....
... newest addition to the Primus family of ... combination of speed and accuracy in a ... volume testing. Test results in 2 minutes ... the lab or clinic., ,The PDQ system ...
... Monoclonal antibody method for HbA1c provides ... shows 99% agreement with the HPLC method(1) ... a CV of 2.6%* means your ... Program (NGSP) certified method, as recommended by ...
... is a manual hemostasis analyzer that ... assays - PTs, aPTTs, thrombins, fibrinogens ... inexpensive, low-volume testing, this analyzer is ... features, offering time and labor saving ...
Medicine Products: